Aprea Therapeutics, Inc. Deferred Tax Liabilities, Gross
Aprea Therapeutics, Inc. (APRE) had Deferred Tax Liabilities, Gross of $26 as of 2022-12-31, per its 10-K filed 2024-03-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2024-03-26
- 2022-12-31: Deferred Tax Liabilities, Gross $26.00.
- 2021-12-31: Deferred Tax Liabilities, Gross $47.34K.
- 2020-12-31: Deferred Tax Liabilities, Gross $70.22K.
- 2019-12-31: Deferred Tax Liabilities, Gross $1.03M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2022-12-31 | $26.00 10-K · filed 2024-03-26 |
| 2021-12-31 | $47.34K 10-K · filed 2023-03-30 |
| 2020-12-31 | $70.22K 10-K · filed 2022-03-15 |
| 2019-12-31 | $1.03M 10-K · filed 2021-03-16 |
| 2018-12-31 | $156.47K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |